BAM
WST icon

Blueshift Asset Management’s West Pharmaceutical WST Stock Holding History

Blueshift Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,067
Closed -$239K – 621
2025
Q1 		$239K Buy
+1,067
New +$294K 0.09% 316
2024
Q3 		– Sell
-1,001
Closed -$330K – 487
2024
Q2 		$330K Buy
1,001
+467
+87% +$165K 0.11% 228
2024
Q1 		$211K Sell
534
-1,265
-70% -$468K 0.11% 251
2023
Q4 		$633K Buy
1,799
+1,178
+190% +$417K 0.34% 81
2023
Q3 		$233K Buy
+621
New +$240K 0.14% 228
2023
Q1 		– Sell
-2,277
Closed -$536K – 475
2022
Q4 		$536K Sell
2,277
-916
-29% -$217K 0.25% 111
2022
Q3 		$786K Sell
3,193
-2,908
-48% -$886K 0.17% 176
2022
Q2 		$1.84M Buy
+6,101
New +$1.99M 0.3% 82
2021
Q4 		– Sell
-15,314
Closed -$6.5M – 1265
2021
Q3 		$6.5M Buy
15,314
+7,412
+94% +$3.12M 0.36% 55
2021
Q2 		$2.84M Buy
+7,902
New +$2.61M 0.16% 164
2021
Q1 		– Sell
-2,685
Closed -$761K – 1103
2020
Q4 		$761K Buy
+2,685
New +$753K 0.09% 319
2020
Q3 		– Sell
-8,783
Closed -$2M – 795
2020
Q2 		$2M Buy
+8,783
New +$1.73M 0.32% 93
2019
Q2 		– Sell
-9,282
Closed -$1.02M – 992
2019
Q1 		$1.02M Buy
+9,282
New +$965K 0.14% 236

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Blueshift Asset Management's WST Position: Q2 2025 in Review

Blueshift Asset Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 1,067 shares — an estimated $239K sold.

Blueshift Asset Management first reported a position in WST in Q1 2019 and held it in 13 quarters. The position peaked at $6.5M in Q3 2021. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Blueshift Asset Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 1,067 West Pharmaceutical shares in Q2 2025, an estimated $239K.
  • Blueshift Asset Management first reported a position in West Pharmaceutical in Q1 2019 and held it in 13 quarters.
  • Blueshift Asset Management's West Pharmaceutical position peaked at $6.5M in Q3 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Blueshift Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.